Location History:
- Minneapolis, MN (US) (2010)
- Carmarillo, CA (US) (2014)
Company Filing History:
Years Active: 2010-2014
Title: Roger Zanon: Innovator in Pharmaceutical Formulations
Introduction
Roger Zanon is a notable inventor based in Camarillo, California. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable emulsion formulations and novel compounds for medical use. With a total of 2 patents, Zanon continues to push the boundaries of innovation in his field.
Latest Patents
Zanon's latest patents include "Stable emulsion formulations" and "Benzomorpholine derivatives and methods of use." The first patent relates to injectable formulations of irritant agents, such as calcimimetics, that are pharmaceutically stable. These formulations demonstrate a reduced incidence of irritation, pain, phlebitis, precipitation, and hemolysis upon injection. The second patent focuses on selected benzomorpholine compounds that are effective for the prophylaxis and treatment of diseases, including those mediated by VEGF. This invention encompasses novel compounds, analogs, prodrugs, and pharmaceutically acceptable salts, along with methods for their use in treating various maladies, including cancer.
Career Highlights
Roger Zanon is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Zanon has collaborated with esteemed colleagues, including Anuradha V Gore and Anne Navratil. These collaborations have further enriched his research and have led to advancements in the field of pharmaceutical formulations.
Conclusion
Roger Zanon is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical science. His contributions continue to pave the way for new treatments and improved patient care.